PANCE Blueprint Infectious Disease (7%)

• Botulism
• Campylobacter jejuni infection
• Chlamydia
• Cholera
• Diphtheria
• Gonococcal infections
• Methicillin-resistant Staphylococcus aureus infection (MRSA)
• Rheumatic fever
• Rocky Mountain spotted fever
• Salmonellosis
• Shigellosis
• Tetanus

Fungal diseases

• Candidiasis
• Cryptococcosis
• Histoplasmosis
• Pneumocystis
• Mycobacterial diseases
• Atypical mycobacterial disease
• Tuberculosis

Parasitic diseases

• Helminth infestations
• Malaria
• Pinworms
• Toxoplasmosis
• Trichomoniasis

Prenatal transmission of disorders

• Congenital varicella
• Herpes simplex virus
• Human papillomavirus
• Zika virus

Sepsis/systemic inflammatory response syndrome

Spirochetal diseases

• Lyme disease
• Syphilis

• Cytomegalovirus infections
• Epstein-Barr virus infections
• Erythema infectiosum
• Herpes simplex virus infections
• HIV infection
• Human papillomavirus infections
• Influenza
• Measles
• Mumps
• Rabies
• Roseola
• Rubella
• Varicella-zoster virus infections

Infectious Disease System Exam

Here is a summary of the new additions/updates to the 2024 PANCE Infectious Diseases System Blueprint that took effect in January of 2025.

• Bacterial diseases → New topics of Bartonella, Chancroid, and C Diff infections
• Fungal diseases → New topics of Blastomycosis and Coccidioidomycosis
• Parasitic diseases → New topics of Amebiasis and Giardiasis
• Prenatal transmission of disorders → New topic of Group B Streptococcus
• New category of Prion disease
• Viral diseases → New topic of Polio